ABSTRACT
Objective:To study the specific mechanism of LINC01018 involved in the pathogenesis of colon cancer.Methods:The expression of LINC01018 in colon cancer tissues and cells and normal colon tissues and cells were detected by real time fluorescence quantitative polymerase chain reaction (qRT-PCR). HT-29 cell line which overexpresses LINC01018 stably was established. RNA binding protein immunoprecipitation (RIP) assay was used to detect the interaction between LINC01018 and E2F1 protein. Dual luciferase assay was used to detect the regulatory effect of E2F1 on CDK6 promoter. The expression of E2F1 or CDK6 was up-regulated in HT-29 cell line which overexpresses LINC01018, then the proliferation, invasion and migration of HT-29 cells and the expression of CDK6 and matrix metalloproteinase-2 (MMP-2) in HT-29 cells were detected by cell counting method (CCK-8) assay, Transwell assay and Western blot.Results:The expression of LINC01018 was abnormally low in colon cancer tissues and cells. The result of RIP assay showed that LINC01018 interacted with E2F1 protein. The result of dual luciferase assay showed that E2F1 protein could enhance the efficiency of CDK6 promoter, and E2F1 had a positive regulatory effect on CDK6. Overexpression of LINC01018 could attenuate the positive regulatory effect of E2F1 on CDK6. Up-regulation of E2F1 or CDK6 expression could attenuate the effects of LINC01018 overexpression on the proliferation, invasion, migration and expression of CDK6 and MMP-2 in HT-29 cells.Conclusions:The expression of LINC01018 was abnormally low in colon cancer tissues and cells. LINC01018 may regulate the proliferation, invasion and migration of HT-29 cells through E2F1/CDK6/MMP-2 axis, and participate in the pathogenesis of colon cancer.
ABSTRACT
Objective To investigate the expression and clinical significance of B7-H1 in normal thyroid tissues adjacent to nodular goiter and thyroid papillary carcinoma.Methods Immunohistochemistry EnVisionTM two step staining method was used to monitor tumor expression of B7-H1, its relationship with clinicopathological features was analyzed.Results The positive reaction of B7-H1 material as brown granules showed positive in cytoplasm, with occasional cell nuclear staining.Positive expression of B7-H1 in papillary thyroid carcinoma tissues 58.2% (39/67) was significantly higher than that 12.5% (2/16) of expression of B7-H1 in the normal thyroid tissues adjacent to nodular goiter.B7-H1 in thyroid papillary carcinoma score 2.94 ± 1.843 was significantly higher than the score 0.88 ± 1.204.(P < 0.01) of B7-H1 in the normal thyroid tissues adjacent to nodular goiter.The average rank of B7-H1 expression in poorly differentiated papillary thyroid carcinoma 40.92 was significantly higher than the average rank expression in papillary thyroid carcinoma with high differentiation in 27.18 and 34.67, the average rank expression in lymph node metastasis in papillary thyroid carcinoma was significantly higher than 35.93 of the average rank expression without lymph node metastasis in papillary thyroid carcinoma (18.75, P <0.01).Conclusions The expression of B7-H1 was significantly higher in papillary thyroid carcinoma than in normal thyroid tissue, and was positively correlated with the degree of differentiation and lymph nodes.